Company logo

BDX - Becton, Dickinson and Company

NYSE -> Healthcare -> Medical Instruments & Supplies
Franklin Lakes, United States
Type: Equity

BDX price evolution
BDX
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Dec 2023
Current assets
Cash $4487 $2394 $1234
Short term investments $851 $827 $2
Net receivables $2596 $2559 $2267
Inventory $3255 $3229 $3304
Total current assets $12207 $10340 $8156
Long term investments
Property, plant & equipment $6518 $6591 $6647
Goodwill & intangible assets $34456 $34826 $35211
Total noncurrent assets $43375 $43817 $44118
Total investments $851 $827 $2
Total assets $55582 $54157 $52274
Current liabilities
Accounts payable $5413 $5311 $5524
Deferred revenue
Short long term debt $1192 $2016 $2016
Total current liabilities $6605 $7327 $7540
Long term debt $18131 $15995 $14094
Total noncurrent liabilities $23109 $21183 $19402
Total debt $19323 $18011 $16110
Total liabilities $29714 $28510 $26942
Shareholders' equity
Retained earnings $16015 $15802 $15540
Other shareholder equity -$1558 -$1510 -$1515
Total shareholder equity $25868 $25647 $25332
(in millions $) 30 Oct 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $1481 $1159 $2392 $2917
Short term investments $8 $8 $12 $20
Net receivables $2534 $2191 $2497 $2398
Inventory $3273 $3224 $2866 $2743
Total current assets $8676 $8141 $8838 $8969
Long term investments
Property, plant & equipment $6557 $6012 $6393 $5923
Goodwill & intangible assets $35470 $36931 $36684 $37433
Total noncurrent assets $44104 $44793 $45028 $45043
Total investments $8 $8 $12 $20
Total assets $52780 $52934 $53866 $54012
Current liabilities
Accounts payable $4245 $4304 $4736 $3993
Deferred revenue
Short long term debt $1141 $2179 $500 $707
Total current liabilities $6641 $7811 $6626 $5836
Long term debt $14738 $13886 $17110 $17224
Total noncurrent liabilities $20343 $19841 $23563 $24411
Total debt $15879 $16065 $17610 $17931
Total liabilities $26984 $27652 $30189 $30247
Shareholders' equity
Retained earnings $15535 $15157 $13826 $12791
Other shareholder equity $25796 -$1488 -$2088 -$2548
Total shareholder equity $25796 $25282 $23677 $23765
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue $4990 $5045 $4706
Cost of revenue $2683 $2741 $2679
Gross Profit $2307 $2304 $2027
Operating activities
Research & development $299 $299 $290
Selling, general & administrative $1196 $1193 $1213
Total operating expenses $1705 $1570 $1589
Operating income $602 $734 $438
Income from continuing operations
EBIT $637 $758 $469
Income tax expense $13 $96 $77
Interest expense $137 $125 $111
Net income
Net income $487 $537 $281
Income (for common shares) $487 $537 $281
(in millions $) 30 Oct 2023 31 Jan 2023 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $19372 $17117
Cost of revenue $9540
Gross Profit $8170 $7577
Operating activities
Research & development $1096
Selling, general & administrative $4325
Total operating expenses $5732 $6093
Operating income $1484
Income from continuing operations
EBIT $1513
Income tax expense $132 $111
Interest expense -$403 $528
Net income
Net income $1424 $874
Income (for common shares) $767
(in millions $) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Oct 2023
Net income $487 $537 $281
Operating activities
Depreciation $568 $571 $561
Business acquisitions & disposals
Stock-based compensation $53 $60 $83
Total cash flows from operations $1265 $514 $841
Investing activities
Capital expenditures -$179 -$134 -$116
Investments -$15 -$815
Total cash flows from investing -$288 -$1056 -$233 -$716
Financing activities
Dividends paid -$275 -$275 -$275 -$1114
Sale and purchase of stock -$500
Net borrowings $1403 $1972
Total cash flows from financing $1120 $1705 -$862 -$1957
Effect of exchange rate -$4 -$3 $7 $5
Change in cash and equivalents $2093 $1160 -$247 $1851
(in millions $) 30 Oct 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $1779 $2092 $874
Operating activities
Depreciation $2229 $2273 $2154
Business acquisitions & disposals -$2070 -$508 -$164
Stock-based compensation $265 $252 $296
Total cash flows from operations $2634 $4647 $3539
Investing activities
Capital expenditures -$973 -$1231 -$810
Investments
Total cash flows from investing -$716 -$3231 -$1880 -$1232
Financing activities
Dividends paid -$1114 -$1082 -$1048 -$1026
Sale and purchase of stock -$500 -$1750 $2917
Net borrowings -$78 -$243 -$1760
Total cash flows from financing -$1957 -$591 -$3306 $22
Effect of exchange rate $5 -$45 $15 -$3
Change in cash and equivalents $1851 -$1233 -$525 $2326
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 1.05
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A